Hoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatment
(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday that it has completed bioanalytical method development under its prior agreement with Altasciences.
The company now plans to further engage Altasciences to perform a key study of mouse blood and plasma analysis from samples collected in Hoth's sponsored scientific research conducted at NC State University.
The blood and plasma samples collected are part of a dose response study in a humanized mouse model.
The upcoming study will use the newly validated bioanalytical method developed at Altasciences to test the amount of HT-KIT from the dose response study and help determine how long HT-KIT remains in the blood stream post dosing.
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews
|
492 дней спустя
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews
|
748 дней спустя
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke
Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.
RTTNews
|
848 дней спустя
German Economy Stuck In Recession
The German economy shrank for the second straight year in 2024 as the euro area struggles with global headwinds and the political and structural problems on the domestic front. Gross domestic product contracted 0.2 percent in 2024 after a 0.3 percent decline in 2023, Destatis reported Wednesday.
RTTNews
|
5ч 59мин назад
U.S. Dollar Slides Against Majors
The U.S. dollar weakened against other major currencies in the European session on Wednesday.
RTTNews
|
6ч 3мин назад
FTSE 100 Advances Over 0.7% On Surprise Drop In Inflation Rate
U.K. stocks are up firmly in positive territory Wednesday morning, outperforming other major markets in Europe, after data showed an unexpected drop in British consumer price inflation in the month of December.
RTTNews
|
6ч 35мин назад
Pound Rebounds After U.K. CPI Data
The British pound rebounded from recent weakness against other major currencies in the European session on Wednesday, after reacting wildly to data showing that U.K. consumer price inflation moderated unexpectedly in December.
RTTNews
|
6ч 48мин назад
CAC 40 Modestly Higher After Inflation Data
French stocks are modestly higher Wednesday morning with investors digesting the nation's consumer price inflation data, and looking ahead to U.S. inflation report for clues about Fed interest rates.
RTTNews
|
6ч 56мин назад
